Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis
Clinical trial NCT02978690 · COMPLETED
Trial details
- NCT number
- NCT02978690
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2017-09-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.